Skip to menu Skip to content Skip to footer

2017

Journal Article

FBXO31 protects against genomic instability by capping FOXM1 levels at the G2/M transition

Jeffery, J. M., Kalimutho, M., Johansson, P., Cardenas, D. G., Kumar, R. and Khanna, K. K. (2017). FBXO31 protects against genomic instability by capping FOXM1 levels at the G2/M transition. Oncogene, 36 (7), 1012-1022. doi: 10.1038/onc.2016.268

FBXO31 protects against genomic instability by capping FOXM1 levels at the G2/M transition

2017

Journal Article

The metastasis suppressor RARRES3 as an endogenous inhibitor of the immunoproteasome expression in breast cancer cells

Anderson, Alison M., Kalimutho, Murugan, Harten, Sarah, Nanayakkara, Devathri M., Khanna, Kum Kum and Ragan, Mark A. (2017). The metastasis suppressor RARRES3 as an endogenous inhibitor of the immunoproteasome expression in breast cancer cells. Scientific Reports, 7 (1) 39873. doi: 10.1038/srep39873

The metastasis suppressor RARRES3 as an endogenous inhibitor of the immunoproteasome expression in breast cancer cells

2016

Journal Article

RNF43 and ZNRF3 are commonly altered in serrated pathway colorectal tumorigenesis

Bond, Catherine E., McKeone, Diane M., Kalimutho, Murugan, Bettington, Mark L., Pearson, Sally-Ann, Dumenil, Troy D., Wockner, Leesa F., Burge, Matthew, Leggett, Barbara A. and Whitehall, Vicki L. J. (2016). RNF43 and ZNRF3 are commonly altered in serrated pathway colorectal tumorigenesis. Oncotarget, 7 (43), 70589-70600. doi: 10.18632/oncotarget.12130

RNF43 and ZNRF3 are commonly altered in serrated pathway colorectal tumorigenesis

2016

Journal Article

Adenosine 2B receptor expression on cancer cells promotes metastasis

Mittal, Deepak, Sinha, Debottam, Barkauskas, Deborah, Young, Arabella, Kalimutho, Murugan, Stannard, Kimberley, Caramia, Franco, Haibe-Kains, Benjamin, Stagg, John, Khanna, Kum Kum, Loi, Sherene and Smyth, Mark J. (2016). Adenosine 2B receptor expression on cancer cells promotes metastasis. Cancer Research, 76 (15), 4372-4382. doi: 10.1158/0008-5472.CAN-16-0544

Adenosine 2B receptor expression on cancer cells promotes metastasis

2016

Journal Article

Understanding the functional impact of copy number alterations in breast cancer using a network modeling approach

Srihari, Sriganesh, Kalimutho, Murugan, Lal, Samir, Singla, Jitin, Patel, Dhaval, Simpson, Peter T., Khanna, Kum Kum and Ragan, Mark A. (2016). Understanding the functional impact of copy number alterations in breast cancer using a network modeling approach. Molecular Biosystems, 12 (3), 963-972. doi: 10.1039/C5MB00655D

Understanding the functional impact of copy number alterations in breast cancer using a network modeling approach

2016

Journal Article

Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancer

French, Juliet D., Johnatty, Sharon E., Lu, Yi, Beesley, Jonathan, Gao, Bo, Kalimutho, Murugan, Henderson, Michelle J., Russell, Amanda J., Kar, Siddhartha, Chen, Xiaoging, Hillman, Kristine M., Kaufmann, S, Sivakumaran H., O'Reilly, Martin, Wang, Chen, Korbie, Darren J., Lambrechts, Diether, Despierre, Evelyn, Van Nieuwenhuysen, Els, Lambrechts, Sandra, Vergote, Ignace, Karlan, Beth, Lester, Jenny, Orsulic, Sandra, Walsh, Christine, Fasching, Peter A., Beckmann, Matthias W., Ekici, Arif B., Hein, Alexander ... MacGregor, Stuart (2016). Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancer. Oncotarget, 7 (6), 6353-6368. doi: 10.18632/oncotarget.7047

Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancer

2015

Journal Article

Targeted Therapies for Triple-Negative Breast Cancer: Combating a Stubborn Disease

Kalimutho, Murugan, Parsons, Kate, Mittal, Deepak, Lopez, J.Alejandro, Srihari, Sriganesh and Khanna, Kum Kum (2015). Targeted Therapies for Triple-Negative Breast Cancer: Combating a Stubborn Disease. Trends in Pharmacological Sciences, 36 (12), 822-846. doi: 10.1016/j.tips.2015.08.009

Targeted Therapies for Triple-Negative Breast Cancer: Combating a Stubborn Disease

2015

Journal Article

Beyond cytokinesis: the emerging roles of CEP55 in tumorigenesis

Jeffery, J., Sinha, D., Srihari, S., Kalimutho, M. and Khanna, K. K. (2015). Beyond cytokinesis: the emerging roles of CEP55 in tumorigenesis. Oncogene, 35 (6), 683-690. doi: 10.1038/onc.2015.128

Beyond cytokinesis: the emerging roles of CEP55 in tumorigenesis

2014

Journal Article

Natural killer cells are essential for the ability of BRAF inhibitors to control BRAFV600E-mutant metastatic melanoma

de Andrade, Lucas Ferrari, Ngiow, Shin F., Stannard, Kimberly, Rusakiewicz, Sylvie, Kalimutho, Murugan, Khanna, Kum Kum, Tey, Siok-Keen, Takeda, Kazyuoshi, Zitvogel, Laurence, Martinet, Ludovic and Smyth, Mark J. (2014). Natural killer cells are essential for the ability of BRAF inhibitors to control BRAFV600E-mutant metastatic melanoma. Cancer Research, 74 (24), 7298-7308. doi: 10.1158/0008-5472.CAN-14-1339

Natural killer cells are essential for the ability of BRAF inhibitors to control BRAFV600E-mutant metastatic melanoma

2014

Journal Article

ADAM17-Dependent c-MET-STAT3 Signaling Mediates Resistance to MEK Inhibitors in KRAS Mutant Colorectal Cancer

Van Schaeybroeck, Sandra, Kalimutho, Murugan, Dunne, Philip D., Carson, Robbie, Allen, Wendy, Jithesh, Puthen V., Redmond, Keara L., Sasazuki, Takehiko, Shirasawa, Senji, Blayney, Jaine, Michieli, Paolo, Fenning, Cathy, Lenz, Heinz-Josef, Lawler, Mark, Longley, Daniel B. and Johnston, Patrick G. (2014). ADAM17-Dependent c-MET-STAT3 Signaling Mediates Resistance to MEK Inhibitors in KRAS Mutant Colorectal Cancer. Cell Reports, 7 (6), 1940-1955. doi: 10.1016/j.celrep.2014.05.032

ADAM17-Dependent c-MET-STAT3 Signaling Mediates Resistance to MEK Inhibitors in KRAS Mutant Colorectal Cancer

2014

Journal Article

Gemcitabine and CHK1 inhibition potentiate EGFR-directed radioimmunotherapy against pancreatic ductal adenocarcinoma

Al-Ejeh, Fares, Pajic, Marina, Shi, Wei, Kalimutho, Murugan, Miranda, Mariska, Nagrial, Adnan M., Chou, Angela, Biankin, Andrew V., Grimmond, Sean M., Brown, Michael P. and Khanna, Kum Kum (2014). Gemcitabine and CHK1 inhibition potentiate EGFR-directed radioimmunotherapy against pancreatic ductal adenocarcinoma. Clinical Cancer Research, 20 (12), 3187-3197. doi: 10.1158/1078-0432.CCR-14-0048

Gemcitabine and CHK1 inhibition potentiate EGFR-directed radioimmunotherapy against pancreatic ductal adenocarcinoma

2014

Journal Article

Meta-analysis of the global gene expression profile of triple-negative breast cancer identifies genes for the prognostication and treatment of aggressive breast cancer

Al-Ejeh, F., Simpson, P. T., Sanus, J. M., Klein, K., Kalimutho, M., Shi, W., Miranda, M., Kutasovic, J., Raghavendra, A., Madore, J., Reid, L., Krause, L., Chenevix-Trench, G., Lakhani, S. R. and Khanna, K. K. (2014). Meta-analysis of the global gene expression profile of triple-negative breast cancer identifies genes for the prognostication and treatment of aggressive breast cancer. Oncogenesis, 3 (4) e100, 1-12. doi: 10.1038/oncsis.2014.14

Meta-analysis of the global gene expression profile of triple-negative breast cancer identifies genes for the prognostication and treatment of aggressive breast cancer

2014

Journal Article

AXL is a key regulator of inherent and chemotherapy-induced invasion and predicts a poor clinical outcome in early-stage colon cancer

Dunne, Philip D., McArt, Darragh G., Blayney, Jaine K., Kalimutho, Murugan, Greer, Samanda, Wang, Tingting, Srivastava, Supriya, Ong, Chee Wee, Arthur, Ken, Loughrey, Maurice, Redmond, Keara, Longley, Daniel B., Salto-Tellez, Manuel, Johnston, Patrick G. and Van Schaeybroeck, Sandra (2014). AXL is a key regulator of inherent and chemotherapy-induced invasion and predicts a poor clinical outcome in early-stage colon cancer. Clinical Cancer Research, 20 (1), 164-175. doi: 10.1158/1078-0432.CCR-13-1354

AXL is a key regulator of inherent and chemotherapy-induced invasion and predicts a poor clinical outcome in early-stage colon cancer

2011

Journal Article

Differential expression of miR-144* as a novel fecal-based diagnostic marker for colorectal cancer

Kalimutho, Murugan, Blanco, Giovanna Del Vecchio, Di Cecilia, Serena, Sileri, Pierpaolo, Cretella, Micaela, Pallone, Francesco, Federici, Giorgio and Bernardini, Sergio (2011). Differential expression of miR-144* as a novel fecal-based diagnostic marker for colorectal cancer. Journal of Gastroenterology, 46 (12), 1391-1402. doi: 10.1007/s00535-011-0456-0

Differential expression of miR-144* as a novel fecal-based diagnostic marker for colorectal cancer

2011

Journal Article

Platinum-(IV)-derivative satraplatin induced G<sub>2</sub>/M cell cycle perturbation via p53-p21<sup>waf1/cip1</sup>-independent pathway in human colorectal cancer cells

Kalimutho, Murugan, Minutolo, Antonella, Grelli, Sandro, Federici, Giorgio and Bernardini, Sergio (2011). Platinum-(IV)-derivative satraplatin induced G2/M cell cycle perturbation via p53-p21waf1/cip1-independent pathway in human colorectal cancer cells. Acta Pharmacologica Sinica, 32 (11), 1387-1396. doi: 10.1038/aps.2011.107

Platinum-(IV)-derivative satraplatin induced G<sub>2</sub>/M cell cycle perturbation via p53-p21<sup>waf1/cip1</sup>-independent pathway in human colorectal cancer cells

2011

Journal Article

Salivary miRNAome profiling uncovers epithelial and proliferative miRNAs with differential expression across dentition stages

Formosa, Amanda, Piro, Maria Cristina, Docimo, Raffaella, Maturo, Paolo, Sollecito, Daniela Rita Maria, Kalimutho, Murugan, Sancesario, Giulia, Barlattani, Alberto, Melino, Gerry, Candi, Eleonora and Bernardini, Sergio (2011). Salivary miRNAome profiling uncovers epithelial and proliferative miRNAs with differential expression across dentition stages. Cell Cycle, 10 (19), 3359-3368. doi: 10.4161/cc.10.19.17647

Salivary miRNAome profiling uncovers epithelial and proliferative miRNAs with differential expression across dentition stages

2011

Journal Article

Satraplatin (JM-216) mediates G2/M cell cycle arrest and potentiates apoptosis via multiple death pathways in colorectal cancer cells thus overcoming platinum chemo-resistance

Kalimutho, Murugan, Minutolo, Antonella, Grelli, Sandro, Formosa, Amanda, Sancesario, Giulia, Valentini, Alessandra, Federici, Giorgio and Bernardini, Sergio (2011). Satraplatin (JM-216) mediates G2/M cell cycle arrest and potentiates apoptosis via multiple death pathways in colorectal cancer cells thus overcoming platinum chemo-resistance. Cancer Chemotherapy and Pharmacology, 67 (6), 1299-1312. doi: 10.1007/s00280-010-1428-4

Satraplatin (JM-216) mediates G2/M cell cycle arrest and potentiates apoptosis via multiple death pathways in colorectal cancer cells thus overcoming platinum chemo-resistance

2011

Journal Article

Epigenetically silenced miR-34b/c as a novel faecal-based screening marker for colorectal cancer

Kalimutho, M., Di Cecilia, S., Blanco, G. Del Vecchio, Roviello, F., Sileri, P., Cretella, M., Formosa, A., Corso, G., Marrelli, D., Pallone, F., Federici, G. and Bernardini, S. (2011). Epigenetically silenced miR-34b/c as a novel faecal-based screening marker for colorectal cancer. British Journal of Cancer, 104 (11), 1770-1778. doi: 10.1038/bjc.2011.82

Epigenetically silenced miR-34b/c as a novel faecal-based screening marker for colorectal cancer

2011

Journal Article

A simplified, non-invasive fecal-based DNA integrity assay and iFOBT for colorectal cancer detection

Kalimutho, Murugan, Blanco, Giovanna Del Vecchio, Cretella, Micaela, Mannisi, Elena, Sileri, Pierpaolo, Formosa, Amanda, Pallone, Francesco, Federici, Giorgio and Bernardini, Sergio (2011). A simplified, non-invasive fecal-based DNA integrity assay and iFOBT for colorectal cancer detection. International Journal of Colorectal Disease, 26 (5), 583-592. doi: 10.1007/s00384-010-1128-x

A simplified, non-invasive fecal-based DNA integrity assay and iFOBT for colorectal cancer detection

2010

Journal Article

Quantitative denaturing high performance liquid chromatography (Q-dHPLC) detection of APC long DNA in faeces from patients with colorectal cancer

Kalimutho, Murugan, Blanco, Giovanna Del Vecchio, Gravina, Paolo, Cretella, Micaela, Mannucci, Liliana, Mannisi, Elena, Formosa, Amanda, Pallone, Francesco, Federici, Giorgio and Bernardini, Sergio (2010). Quantitative denaturing high performance liquid chromatography (Q-dHPLC) detection of APC long DNA in faeces from patients with colorectal cancer. Clinical Chemistry and Laboratory Medicine, 48 (9), 1303-1311. doi: 10.1515/CCLM.2010.245

Quantitative denaturing high performance liquid chromatography (Q-dHPLC) detection of APC long DNA in faeces from patients with colorectal cancer